Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapy

Constanza Martinez; Rie N Asso; Neelabh Rastogi; Carolyn R Freeman; Fabio L Cury

doi:10.1016/j.radonc.2024.110239

Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapy

Radiother Oncol. 2024 Mar 21:195:110239. doi: 10.1016/j.radonc.2024.110239. Online ahead of print.

Authors

Constanza Martinez¹, Rie N Asso¹, Neelabh Rastogi², Carolyn R Freeman¹, Fabio L Cury³

Affiliations

¹ Division of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada.
² Department of Medicine, McGill University, Montreal, Quebec, Canada.
³ Division of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: fabio.cury@mcgill.ca.

PMID: 38521165
DOI: 10.1016/j.radonc.2024.110239

Abstract

Purpose/objective: This study aims to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in soft tissue sarcomas (STS) treated with pre-operative hypofractionated radiotherapy (HFRT).

Materials/methods: This retrospective analysis included patients treated with pre-operative HFRT of 30 Gy in 5 fractions between 2016 and 2023. Clinical, demographic, and complete blood count (CBC) data were collected. NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. Only patients with CBCs conducted within 6 months after radiotherapy were included. Cox proportional-hazard regression models were used to assess the impact of NLR and different variables on outcomes. Kaplan Meier were used to illustrate survival curves. A p-value < 0.05 was considered significant, and 95 % confidence intervals (CI) were employed.

Results: A total of 40 patients received HFRT and had CBCs within 6 months after radiotherapy. There were 17 (42.5 %) females and 23 (57.5 %) males with a mean age of 66 years. The mean largest tumor size dimension was 7.1 cm, and the mean NLR post-RT was 5.3. The most frequent histological subtypes were myxofibrosarcoma (17.5 %), pleomorphic spindle cell sarcoma (10 %), leiomyosarcoma (7.5 %), and myxoid liposarcoma (5 %). The median follow-up period was 15.4 months. From all patients, 14 patients had disease progression, 12 metastatic disease and 3 died of disease. Multivariable Cox proportional-hazards regression analysis displayed that a higher post-RT NLR was associated with worse disease-free survival (DFS) (HR: 1.303 [1.098-1.548], p = 0.003), and distant metastasis-free survival (DMFS) (HR: 1.38 [1.115-1.710], p = 0.003). Moreover, post-NLR ≥ 4 as a single variable was associated with worse DFS, DMFS, but not worse local recurrence or overall survival.

Conclusion: This study is the first to evaluate NLR as a prognostic biomarker in STS patients treated with pre-operative radiotherapy. A higher NLR after pre-operative radiotherapy was associated with increased disease progression.

Keywords: Neutrophil-to-lymphocyte ratio; Prediction; Soft tissue sarcomas.